Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the ...

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...

IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2024 earnings per share (EPS) of $2.62, up 12.9% year over year. The ...

IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

IDEXX Laboratories, Inc. (IDXX) is up by 11.55 percent during Friday morning trading, following the release of its fourth-quarter ...

U.S. stock indexes closed lower Monday but rebounded from earlier steep losses after President Donald Trump delayed new ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...

Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...

Reports Q4 revenue $954M, consensus $936.68M. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams ...